azt clear children use first aid drug health fda action expect make antivir medicin avail pediatr use food drug administr thursday formal approv antivir aid drug azt treat children make first aid drug sanction standard therapi pediatr use drug approv use patient three month 12 year old fulli develop aid infect aid viru show sign damag immun system measur laboratori test latter group need overt symptom diseas drug alreadi approv adolesc adult azt clearli benefit children said dr dan hoth director divis aid nation institut allergi infecti diseas govern lead aid research agenc approv easier children get access drug think extrem import mileston develop therapeut diseas first drug children thursday action expect pave way rapid test approv addit aid drug pediatr use feder govern increas pressur make aid treatment clinic trial experiment aid drug access children sinc recent noth avail except also long stand fda polici drug kind cannot test children made avail studi approv use adult hoth said least three antivir aid drug ddi dideoxyinosin ddc dideoxycytidin cd4 current studi children 128 319 report case aid countri sinc 1981 2 192 case children younger 13 accord feder center diseas control 1 182 children die reliabl estim number children infect viru although expert specul figur high 10 000 azt also known zidovudin alreadi widespread use children sinc last fall fda permit access drug compassion reason pediatr azt research continu time howev burrough wellcom manufactur azt provid drug free fda decis offici approv drug children mean medicaid privat insur third parti payer like cover cost fda approv azt pediatr use mean drug offici consid standard therapi children aid health human servic secretari loui w sullivan said statement statu encourag insur provid reimburs zidovudin use pediatr drug whose dosag children determin bodi surfac size cost averag 1 750 year child avail strawberri flavor syrup excit look see happen next drug said susan delaurenti co founder lo angel base pediatr aid foundat rais money pediatr aid research encourag drug compani fda test drug faster children approv faster delaurenti ad start happen hope learn exampl azt fda action came antivir drug product advisori committe panel outsid expert recommend march 30 drug approv pediatr use compani caution howev children younger 15 month age undergo sophist confirmatori test infect viral cultur begin azt therapi commonli perform test aid infect indic presenc antibodi aid viru children age whose mother infect often still carri antibodi mean may necessarili infect azt approv adult use 1987 studi formal trial 200 children sinc 1986 drug approv sale physician often prescrib see fit even unapprov use case azt mani health profession reluct give children afraid side effect may sever patient popul azt caus toxic reaction includ sever anemia requir blood transfus find pediatr trial shown children take azt experi side effect similar adult studi also demonstr children take azt experi benefit adult prolong surviv reliev symptom encourag weight gain enhanc qualiti life